Latest Period
n/a
Security Snapshot
4D MOLECULAR THERAPEUTICS IN - COM Institutional Ownership
CUSIP: 35104E100
13F Institutional Holders and Ownership History from Q4 2023 to Q3 2024
Institutions Reporting
Shares (Excl. Options)
Price
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.
- Type / Class
- Equity / COM
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- 35104E100 - 4D MOLECULAR THERAPEUTICS IN - COM is tracked under CUSIP 35104E100.
- Latest finished 13F holder period is not available.
- Schedule 13D/13G significant owner rows are not currently available.
What Changed
- Holder count moved from 2 to 1 between Q2 2024 and Q3 2024.
- Reported value moved from $146,429,870 to $22,879,451.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Schedule 13D/G
Open SEC Evidence
Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.
Investment Quick Answers
What is CUSIP 35104E100?
CUSIP 35104E100 identifies 35104E100 - 4D MOLECULAR THERAPEUTICS IN - COM in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 35104E100: